Stay updated on ALN-TTRSC SubQ Clinical Trial
Sign up to get notified when there's something new on the ALN-TTRSC SubQ Clinical Trial page.

Latest updates to the ALN-TTRSC SubQ Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding ALN-TTRSC and its associated criteria, while adding references to TTR-mediated Amyloidosis and a new revision number.SummaryDifference17%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check103 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check111 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to ALN-TTRSC SubQ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALN-TTRSC SubQ Clinical Trial page.